| 言語 |
英語
|
| 著者 |
Harashima Nanae
Department of Immunology, Faculty of Medicine, Shimane University, Shimane, Japan
Motoshima Takanobu
Department of Urology, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan
Komohara Yoshihiro
Department of Cell Pathology, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan
Eto Masatoshi
Department of Urology, Graduate School of Medical Science, Kyushu University, Fukuoka, Japan
|
| 主題 | Anti-CTLA-4 therapy; CCL2; cyclophosphamide; IL-6; MDSC
|
| 掲載誌名 |
CANCER SCIENCE
|
| 巻 | 108
|
| 号 | 10
|
| 開始ページ | 1974
|
| 終了ページ | 1984
|
| ISSN | 1347-9032
|
| ISSN（Online） | 1349-7006
|
| 発行日 | 2017-10
|
| DOI | |
| PubMed ID | |
| 出版者 | WILEY
|
| 資料タイプ |
学術雑誌論文
|
| 部局 |
医学部
|
| 備考 | JSPS KAKENHI, (17K07217); The Shimane University SUIGANN Project.
|
